Aminocaproic Acid (VersaPharm Incorporated)


Welcome to the PulseAid listing for the Aminocaproic Acid drug offered from VersaPharm Incorporated. This Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: VersaPharm Incorporated
NON-PROPRIETARY NAME: Aminocaproic Acid
SUBSTANCE NAME: AMINOCAPROIC ACID
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 2012-06-01
END MARKETING DATE: 0000-00-00


Aminocaproic Acid HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAminocaproic Acid from VersaPharm Incorporated
LABELER NAME: VersaPharm Incorporated
DEA SCHEDULE:
ACTIVE STRENGTH: 1000(mg/1)
START MARKETING DATE: 2012-06-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 61748-046_49a23821-76f9-45a4-a79b-aff14769bad1
PRODUCT NDC: 61748-046
APPLICATION NUMBER: NDA015197

Other AMINOCAPROIC ACID Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Regent, Inc.Aminocaproic Acid
Avera McKennan HospitalAMICAR
Clover Pharmaceuticals Corp.AMICAR
Hospira, Inc.Aminocaproic Acid
VersaPharm IncorporatedAminocaproic Acid